Dermatologas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 363,766 | 336,923 | 294,421 | 284,415 | 297,031 | 418,343 | 502,074 | 521,242 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 173,090 | 145,981 | 150,144 | 133,403 | 123,055 | 177,167 | 235,478 | 240,818 |
| Equity | 176,457 | 149,438 | 299,582 | 136,785 | 153,958 | 180,353 | 238,664 | 244,004 |
| Liabilities | 28,904 | 11,613 | 4,233 | 2,141 | 9,031 | 32,147 | 23,901 | 14,997 |
| Non-current assets | 64,403 | 40,246 | 33,663 | 24,900 | 15,141 | 5,966 | 2,493 | 72,159 |
| Current assets | 5,668 | 3,256 | 269,880 | 113,803 | 147,410 | 206,058 | 259,354 | 184,816 |
| Total assets | 70,071 | 43,502 | 303,543 | 138,703 | 162,551 | 212,024 | 261,847 | 256,975 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 50,167 | 105,277 | 125,897 |
| Social insurance contributions | - | - | - | - | - | 33,020 | 40,528 | 41,579 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +84.5% | -7.4% | -12.6% | -3.4% | +4.4% | +40.8% | +20.0% | +3.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 247.0% | 335.6% | 49.5% | 96.2% | 75.7% | 83.6% | 89.9% | 93.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 98.1% | 97.7% | 50.1% | 97.5% | 79.9% | 98.2% | 98.7% | 98.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 47.6% | 43.3% | 51.0% | 46.9% | 41.4% | 42.3% | 46.9% | 46.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.1 | 0.0 | 0.0 | 0.1 | 0.2 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 40,796 | 33,140 | 30,457 | 31,602 | 33,626 | 41,834 | 49,384 | 47,386 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dermatologas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-05-16 | 2024-06-10 | 0.04 |
| 2024-04-23 | 2024-05-13 | 0.04 |
| 2022-01-28 | 2022-02-13 | 0.08 |
| 2021-12-16 | 2021-12-19 | 44.27 |
| 2021-11-16 | 2021-11-18 | 34.04 |
Dermatologas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-05 | 2025-05-08 | 5.43 |
| 2025-05-03 | 2025-05-04 | 5.17 |
| 2025-05-01 | 2025-05-02 | 480.17 |
| 2025-04-02 | 2025-04-28 | 0.1 |
| 2025-03-20 | 2025-04-01 | 0.7 |
| 2024-12-19 | 2025-02-10 | 0.41 |
| 2024-11-01 | 2024-12-10 | 1.35 |
| 2024-10-15 | 2024-10-31 | 1.76 |
| 2024-10-01 | 2024-10-14 | 1.35 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dermatologas, UAB is a Private Limited Liability Company (code 303426606) operating in medical specialists activities. In 2025, the latest financial year, the company generated revenue of €521.2K and net profit of €240.8K, resulting in a profit margin of 46.2%. Revenue increased from €418.3K in 2023 to €502.1K in 2024 and then to €521.2K in 2025, while net profit rose from €177.2K to €235.5K and then to €240.8K. This points to a steady upward trajectory over the three-year period, with growth moderating in 2025. The balance sheet remained strong, with total assets of €257.0K and equity of €244.0K in 2025, while liabilities declined to €15.0K. Equity represented 95.0% of assets and the debt-to-equity ratio stood at 0.06. Asset turnover was 2.03x, indicating efficient use of assets. Profitability ratios were very high, with ROE at 98.7% and ROA at 93.7%. Revenue per employee was €47.4K and profit per employee €21.9K.